Private Equity
Gut feelings are great, but data is better. It’s time for private equity to get in the game.
4 min read · 17 September 2020
In a disruptive, uncertain time, distressed situations present opportunities to acquire assets at bargain prices.
3 min read · 16 September 2020
When structured and executed correctly, private equity can be a powerful vehicle for change at a time when change is what the healthcare system needs.
4 min read · 04 September 2020
The perfect storm of the pandemic, economic woes and the call for racial justice has highlighted the social aspect of responsible investing, writes Eamon Murphy
5 min read · 03 September 2020
The focus on ESG is growing, yet few lower mid-market private equity fund managers have made it a priority, say John Poff, David Walden and Bonnie Howard of MiddleGround Capital.
7 min read · 01 September 2020
Tom Walker of Rev1 Ventures addresses the question of whether investors should back biotech start-ups that focus on the coronavirus and other potential pandemics. Here's what you should know.
4 min read · 25 August 2020
The outcome of a (successful) transformation process enables finance to move from scorekeeper to forward-looking business partner.
4 min read · 20 August 2020
Sponsors are facing direct exposure and liability as a result of increased scrutiny by the Department of Justice and other enforcement agencies.
4 min read · 17 August 2020
William Taranto of the Merck Global Health Innovation Fund writes how the switch to working from home can make investors more productive. But the downside is loss of personal interaction.
3 min read · 04 August 2020
Times are difficult right now, but promising signs in regard to deals terms, impact investing and engagement are boding well, writes Oliver Libby, managing partner and co-founder of venture firm Hatzimemos / Libby.
3 min read · 30 July 2020
